Rallybio Corporation

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Rallybio Corporation
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
RLYB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001739410

Board of directors

Follow this board

Chief executives

Martin Mackay · Chief Executive Officer
Dates unknown
Stephen Uden · Chief Executive Officer
Dates unknown

Board connections

5 of this board's directors also sit on 7 other boards.

Network of Rallybio Corporation's board connections Charles River Laboratories International Inc. Charles River Laborato... Dianthus Therapeutics Inc. Dianthus Therapeutics... Entrada Therapeutics Inc. Entrada Therapeutics I... Prime Medicine Inc. Prime Medicine Inc. Shattuck Labs Inc. Shattuck Labs Inc. Tvardi Therapeutics Inc. Tvardi Therapeutics In... uniQure N.V. uniQure N.V. Helen M. Boudreau Helen M. Boudreau Kush Parmar Kush Parmar Martin Mackay Martin Mackay Paula Soteropoulos Paula Soteropoulos Wendy Chung Wendy Chung Rallybio Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Mar 14, 2023 Jonathan I. Lieber Officer (See Remarks) Open-market purchase +5,000 $5.21 $26,050
Mar 7, 2023 Kush Parmar Director Open-market sale −100,000 $8.20 $820,000
Mar 7, 2023 Andrew J. Schwab 10% owner Open-market sale −100,000 $8.20 $820,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.